CIDARA THERAPEUTICS INC (CDTX)
US1717572069 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 127.39M | 35.78M | 32.73M | 59.68M | 35.91M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 1.70M | 16.25M | 5.83M | 5.36M | 11.18M | |||
| Inventories | N/A | 6.10M | 0.00 | N/A | N/A | |||
| Other Current Assets | 27.69M | 2.73M | 6.53M | 6.66M | 10.10M | |||
| Total Current Assets | 156.77M | 60.85M | 45.09M | 71.70M | 57.19M | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.32M | 5.13M | 1.32M | 2.54M | 1.21M | |||
| Other Non-Current Assets | 1.24M | 1.05M | 1.07M | 1.08M | 2.02M | |||
| Total Non-Current Assets | 5.56M | 6.17M | 2.39M | 3.63M | 3.23M | |||
| TOTAL ASSETS | 162.33M | 67.03M | 47.49M | 75.33M | 60.42M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 259.00K | 218.00K | 0.00 | 2.59M | 7.02M | |||
| Accrued Expenses | 41.11M | 38.33M | 25.34M | 16.20M | 13.11M | |||
| Accounts Payable | 2.97M | 3.77M | 1.45M | 1.30M | 4.57M | |||
| Other Current Liabilities | 0.00 | 25.09M | 14.61M | 13.92M | 13.87M | |||
| Total Current Liabilities | 44.34M | 67.42M | 41.40M | 34.02M | 38.56M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 378.00K | 575.00K | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 1.98M | 7.25M | 20.52M | 19.73M | 11.14M | |||
| Total Non-Current Liabilities | 2.36M | 7.82M | 20.52M | 19.73M | 11.14M | |||
| TOTAL LIABILITIES | 46.70M | 75.24M | 61.92M | 53.75M | 49.71M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -558.95M | -441.43M | -418.50M | -377.17M | -334.70M | |||
| Additional Paid In Capital | 674.58M | 433.21M | 404.06M | 398.73M | 345.41M | |||
| Common Shares | 1.00K | 9.00K | 7.00K | 7.00K | 4.00K | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 7.05M | 4.53M | 3.62M | 3.39M | 2.24M | |||
| Tangible Book Value per Share | 16.41 | -1.81 | -3.98 | 6.36 | 4.77 | |||
| Total Shareholders' Equity | 115.63M | -8.21M | -14.44M | 21.57M | 10.71M | |||
| TOTAL LIABILITIES AND EQUITY | 162.33M | 67.03M | 47.49M | 75.33M | 60.42M | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | -0.07 | N/A | N/A | N/A | |||
| Current Ratio | 3.54 | 0.90 | 1.09 | 2.11 | 1.48 | |||
| Return On Assets (ROA) | -75.85% | -34.21% | -70.72% | -56.38% | -123.91% | |||
| Return On Equity (ROE) | -106.49% | N/A | N/A | -196.85% | -698.77% | |||
All data in USD , ROIC based on taxRate of 0.21